Guidelines that avoid the use of oral antidiabetes agents associated with hypoglycemia and weight gain are becoming increasingly popular in treating patients with diabetes. What are we learning about incretin-based therapies in both the intensive care and emergency medicine departments and perioperatively? Join host Dr. Steven Edelman and his guest, associate professor of medicine at the University of Pennsylvania, Dr. Stanley Schwartz, as they discuss the surprising results in both intensive care, emergency medicine and perioperative periods using incretin-based therapies.
Facebook Comments